We are live on ! Find out more
GMAB icon

Genmab
GMAB

133 hedge funds and large institutions have $564M invested in Genmab in 2019 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 41 increasing their positions, 27 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 13

52% more repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 27

37% more funds holding

Funds holding: 97 → 133 (+36)

11% more capital invested

Capital invested by funds: $511M → $564M (+$53.8M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.36% less ownership

Funds ownership: 38.78% → 36.42% (-2.4%)

Holders
133
Holders Change
+36
Holders Change %
+37.11%
% of All Funds
2.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
50
Increased
41
Reduced
27
Closed
13
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$7.55M
2
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$5.33M
3
Bank of America
Bank of America
North Carolina
+$4.29M
4
CS
Candriam SCA
Luxembourg
+$4.2M
5
FAM
Fred Alger Management
New York
+$4.08M

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$15.6M
2
HM
HealthCor Management
New York
-$14.1M
3
TIP
Torray Investment Partners
Maryland
-$11.8M
4
RG
Redmile Group
California
-$6.81M
5
SIG
Senator Investment Group
New York
-$6.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
OSAM
101
O'Shaughnessy Asset Management
Connecticut
$19K +$18.6K +851 New
PA
102
Procyon Advisors
Connecticut
$16K +$15.3K +700 New
EW
103
Evoke Wealth
California
$14.2K – – –
CQS
104
Credential Qtrade Securities
$11.1K +$2.53K +116 +31%
BCA
105
Berman Capital Advisors
Georgia
$11K – – –
PCIA
106
Prime Capital Investment Advisors
Kansas
$10K – – –
ASN
107
Advisory Services Network
Georgia
$9K +$8.9K +408 New
Rockefeller Capital Management
108
Rockefeller Capital Management
New York
$8K -$6.15K -282 -43%
EFSCE
109
Enterprise Financial Services Corp (EFSC)
Missouri
$8K +$655 +30 +9%
MF
110
Manchester Financial
California
$8K +$7.53K +345 New
Fifth Third Bancorp
111
Fifth Third Bancorp
Ohio
$8K +$7.88K +361 New
ZB
112
Zions Bancorporation
Utah
$7K – – –
CFGS
113
Concourse Financial Group Securities
Alabama
$6K – – –
CCA
114
Column Capital Advisors
Indiana
$6K +$6.57K +301 New
PA
115
Parallel Advisors
California
$5K +$5.06K +232 New
FCA
116
FinTrust Capital Advisors
South Carolina
$4K – – –
Daiwa Securities Group
117
Daiwa Securities Group
Japan
$4K +$3.73K +171 New
Barclays
118
Barclays
United Kingdom
$3K -$88.6K -4,062 -97%
TFGT
119
TS Financial Group (TSFG)
Illinois
$3K -$284 -13 -10%
BC
120
Barnett & Company
Tennessee
$3K +$3.16K +145 New
CFA
121
Carroll Financial Associates
North Carolina
$3K +$3.54K +162 New
Northwestern Mutual Wealth Management
122
Northwestern Mutual Wealth Management
Wisconsin
$2K -$393 -18 -21%
WCM
123
Wealthcare Capital Management
Virginia
$2K +$2.14K +98 New
Group One Trading
124
Group One Trading
Illinois
$2K +$2.18K +100 New
SL
125
Savior LLC
Massachusetts
$1K +$720 +33 New
2 3 4
5
6

GMAB Hedge Fund Activity: Q4 2019 in Review

133 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q4 2019, worth a combined $564M — up 11% from $511M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new GMAB positions and 13 closed out — a net gain of 37 holders — while 41 added to existing stakes and 27 trimmed.

The largest buyer was BlackRock, adding an estimated $7.55M. The largest seller was Citadel Advisors, cutting an estimated $15.6M.

  • 133 institutional investors held Genmab (GMAB) as of Q4 2019, up from 97 in Q3 2019.
  • Funds reported $564M of Genmab stock for Q4 2019, up 11% quarter-over-quarter.
  • 50 funds opened new Genmab positions in Q4 2019 and 13 closed out, a net change of +37 holders.
  • The largest Genmab buyer in Q4 2019 was BlackRock, an estimated $7.55M added.
  • The largest Genmab seller in Q4 2019 was Citadel Advisors, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2019.